J. Mares

发表

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Manal M. Hassan, Douglas B. Evans, E. Abdalla, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physician assistants in oncology.

J. Mares, E. Tetzlaff, Maura N. Polansky, 2007, Journal of oncology practice.

Phase II study of RAD001 (everolimus) and depot octreotide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma (LGNET)

F. Meric-Bernstam, R. Wolff, A. Phan, 2007 .

Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience.

J. Ajani, P. Das, A. Matamoros, 2016, Journal of gastrointestinal oncology.

Population based study of islet cell carcinoma

Douglas B. Evans, M. Eisner, James C Yao, 2007 .

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

K. Hess, A. Rashid, F. Meric-Bernstam, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2017, Annals of Surgical Oncology.

Improving the Success Rate of Gluteal Intramuscular Injections

April E. Boyd, A. Phan, C. Leary, 2013, Pancreas.

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

J. Ajani, W. Hofstetter, R. Slack, 2016, Oncology.

Gender Related Issues in Gluteal Intramuscular Injections

April E. Boyd, A. Phan, Cecile G. Dagohoy, 2010 .

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma

N. Sneige, J. Ajani, S. Swisher, 2017, Oncotarget.

Increased rates of hypertension (HTN) among patients with advanced carcinoid treated with bevacizumab

J. Ajani, Helen X. Chen, P. Hoff, 2005 .

Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET).

F. Meric-Bernstam, A. Phan, J. Mares, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.

J. Ajani, J. Mares, M. B. Blum Murphy, 2024, International journal of cancer.

Gluteal Intramuscular Injections: Techniques Associated With Successful Octreotide LAR Injection

Cecile G. Dagohoy, C. Leary, J. Mares, 2010 .